Analysis of benzodiazepine withdrawal program managed by primary care nurses in Spain
- PMID: 23237104
- PMCID: PMC3598901
- DOI: 10.1186/1756-0500-5-684
Analysis of benzodiazepine withdrawal program managed by primary care nurses in Spain
Abstract
Background: Benzodiazepine (BZD), the long-term treatment of which is harmful for cognitive function, is widely prescribed by General Practitioners in Spain. Based on studies performed in other countries we designed a nurse-led BZD withdrawal program adapted to Spanish Primary Care working conditions.
Results: A pseudo-experimental (before-after) study took place in two Primary Care Centres in Barcelona. From a sample of 1150 patients, 79 were identified. They were over 44 years old and had been daily users of BZD for a period exceeding six months. Out of the target group 51 patients agreed to participate. BZD dosage was reduced every 2-4 weeks by 25% of the initial dose with the optional support of Hydroxyzine or Valerian. The rating measurements were: reduction of BZD prescription, demographic variables, the Short-Form Health Survey (SF-12) to measure quality of life, the Medical Outcomes Study (MOS) Sleep Scale, and the Goldberg Depression and Anxiety Scale.By the end of the six-month intervention, 80.4% of the patients had discontinued BZD and 64% maintained abstinence at one year. An improvement in all parameters of the Goldberg scale (p <0.05) and in the mental component of SF-12 at 3.3 points (p = 0.024), as well as in most components of the MOS scale, was observed in the group that had discontinued BZD. No significant differences in these scales before and after the intervention were observed in the group that had not discontinued.
Conclusions: At one year approximately 2/3 of the patients had ceased taking BZD. They showed an overall improvement in depression and anxiety scales, and in the mental component of the quality of life scale. There was no apparent reduction in the sleep quality indicators in most of the analysed components. Nurses in a Primary Care setting can successfully implement a BZD withdrawal program.
Figures
Similar articles
-
Efficacy of two interventions on the discontinuation of benzodiazepines in long-term users: 36-month follow-up of a cluster randomised trial in primary care.Br J Gen Pract. 2016 Feb;66(643):e85-91. doi: 10.3399/bjgp16X683485. Br J Gen Pract. 2016. PMID: 26823269 Free PMC article. Clinical Trial.
-
[Comparison of 6 different methods for lorazepam withdrawal. A controlled study, hydroxyzine versus placebo].Encephale. 1997 Jul-Aug;23(4):290-9. Encephale. 1997. PMID: 9417395 Clinical Trial. French.
-
Benzodiazepine tapering: a prospective study.Nord J Psychiatry. 2010 Aug;64(4):273-82. doi: 10.3109/08039481003624173. Nord J Psychiatry. 2010. PMID: 20629611
-
Novel Augmentation Strategies in Major Depression.Dan Med J. 2017 Apr;64(4):B5338. Dan Med J. 2017. PMID: 28385173 Review.
-
[In utero exposure to benzodiazepine. Is there a risk for anal atresia with lorazepam?].Encephale. 2003 Nov-Dec;29(6):553-9. Encephale. 2003. PMID: 15029090 Review. French.
Cited by
-
Prescription of potentially inappropriate medications in elderly outpatients: a survey using 2015 Japanese Guidelines.Int J Clin Pharm. 2020 Apr;42(2):579-587. doi: 10.1007/s11096-020-00967-9. Epub 2020 Jan 21. Int J Clin Pharm. 2020. PMID: 31960272 Free PMC article.
-
Cognitive Behavioral Therapy and Acceptance and Commitment Therapy for the Discontinuation of Long-Term Benzodiazepine Use in Insomnia and Anxiety Disorders.Int J Environ Res Public Health. 2021 Sep 28;18(19):10222. doi: 10.3390/ijerph181910222. Int J Environ Res Public Health. 2021. PMID: 34639523 Free PMC article. Review.
-
Addressing Barriers to Reducing Prescribing and Implementing Deprescribing of Sedative-Hypnotics in Primary Care.Ann Pharmacother. 2022 Apr;56(4):463-474. doi: 10.1177/10600280211033022. Epub 2021 Jul 23. Ann Pharmacother. 2022. PMID: 34301151 Free PMC article.
-
Deprescribing Benzodiazepines in Older Patients: Impact of Interventions Targeting Physicians, Pharmacists, and Patients.Drugs Aging. 2018 Jun;35(6):493-521. doi: 10.1007/s40266-018-0544-4. Drugs Aging. 2018. PMID: 29705831 Review.
-
A review of the management of antidepressant discontinuation symptoms.Ther Adv Psychopharmacol. 2015 Dec;5(6):357-68. doi: 10.1177/2045125315612334. Ther Adv Psychopharmacol. 2015. PMID: 26834969 Free PMC article. Review.
References
-
- Leipzig RM, Cumming RG, Tinetti ME. Drugs and fall in older people: a systematic review and meta-analysis: I Psychotropic drugs. J Am Geriatr Soc. 1999;47:30–39. - PubMed
-
- Rang HP, Dale MM, Ritter JM. Pharmacology. 4ªth. London: Harcourt Publishers Limited; 2000.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical